Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Beitsch

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Oncology Practice|January 14, 2017
Impact of Payer Constraints on Access to Genetic TestingPat Whitworth, Peter Beitsch, Christopher Arnell, et al.
Annals of Surgical Oncology|July 24, 2012
Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast SurgeonsSarah M Gainer, Kelly K Hunt, Peter Beitsch, et al.
Annals of Surgical Oncology|August 27, 2013
Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trialChirag Shah, Shahed Badiyan, J Ben Wilkinson, et al.
American Journal of Surgery|September 29, 2004
Progressive adoption of cryoablative therapy for breast fibroadenoma in community practiceMichael J Edwards, Ralph Broadwater, Lorraine Tafra, et al.
Brachytherapy|May 14, 2013
Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesisChirag Shah, Shariq Khwaja, Shahed Badiyan, et al.
American Journal of Surgery|October 6, 2009
American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesionsMartin Keisch, Frank Vicini, Peter Beitsch, et al.
NPJ Breast Cancer|April 25, 2019
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancersFloris H Groenendijk, Tina Treece, Erin Yoder, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiationFrank Vicini, Peter Beitsch, Coral Quiet, et al.
International Journal of Molecular Sciences|January 25, 2025
Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine-Biology Is Still KingRakhshanda Layeequr Rahman, Alfredo Santillan, Mehran Habibi, et al.
The Breast Journal|January 22, 2026
Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast CarcinomaDivya Rao, Chloe Wernecke, Lisa Baron, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Oncology Practice|January 14, 2017
Impact of Payer Constraints on Access to Genetic TestingPat Whitworth, Peter Beitsch, Christopher Arnell, et al.
Annals of Surgical Oncology|July 24, 2012
Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast SurgeonsSarah M Gainer, Kelly K Hunt, Peter Beitsch, et al.
Annals of Surgical Oncology|August 27, 2013
Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trialChirag Shah, Shahed Badiyan, J Ben Wilkinson, et al.
American Journal of Surgery|September 29, 2004
Progressive adoption of cryoablative therapy for breast fibroadenoma in community practiceMichael J Edwards, Ralph Broadwater, Lorraine Tafra, et al.
Brachytherapy|May 14, 2013
Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesisChirag Shah, Shariq Khwaja, Shahed Badiyan, et al.
American Journal of Surgery|October 6, 2009
American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesionsMartin Keisch, Frank Vicini, Peter Beitsch, et al.
NPJ Breast Cancer|April 25, 2019
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancersFloris H Groenendijk, Tina Treece, Erin Yoder, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiationFrank Vicini, Peter Beitsch, Coral Quiet, et al.
International Journal of Molecular Sciences|January 25, 2025
Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine-Biology Is Still KingRakhshanda Layeequr Rahman, Alfredo Santillan, Mehran Habibi, et al.
The Breast Journal|January 22, 2026
Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast CarcinomaDivya Rao, Chloe Wernecke, Lisa Baron, et al.
Pageof 5